The histopathology of treated Barrett's esophagus: Squamous reepithelialization after acid suppression and laser and photodynamic therapy

American Journal of Surgical Pathology

Volumn 22, Issue 2, 1998, Pages 239-245

  Biddlestone, L R ^a   Barham, C P ^a   Wilkinson, S P ^b   Barr, H ^a   Shepherd, N A ^a,c  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Barrett's esophagus; Columnar lined esophagus; Dysplasia; Laser therapy; Photodynamic therapy; Proton pump inhibitors

Indexed keywords

ANTACID AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS DISEASE; ESOPHAGUS MUCOSA; FEMALE; HISTOPATHOLOGY; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; PHOTODYNAMIC THERAPY;

AGED; BARRETT ESOPHAGUS; FEMALE; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROTON PUMPS;

EID: 0031890975     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199802000-00013     Document Type: Article

References (24)

1. Barr H, Shepherd NA, Dix A, Roberts DJH. Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barren's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348:584-5.
2. Berenson MM, Johnson TD, Markowitz NR, Buchi KM, Samowitz WS. Restoration of squamous inucosa after ablation of Barrett's oesophageal epithelium. Gastroenterology 1993;104:1686-91.
3. Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993;270:1320.
4. Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett's epithelium. Castrointest Enclose 1992;38:619-22.
5. Clark GWB, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-14.
6. DeNardi FG, Riddell RH. Esophagus. In: Sternberg SS, ed. Histology for Pathologists. New York: Raven, 1992:515-32.
7. Ertan A, Zimmerman M, Younes M. Esophageal adenocarcinoma associated with Barrett's esophagus: long-term management with laser ablation. Am J Gastroenterol 1995;90:2201-3.
8. Gillen P, Keeling P, Byrne PJ, West AB, Hennessy TPJ. Experimental columnar metaplasia in the canine oesophagus. Br J Surg 1988;75:113-5.
9. Gore S, Healey CJ, Sutton R, Eyre-Brook IA, Gear MWL, Shepherd NA, Wilkinson SP. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993;7:623-8.
10. Hameeteman W, Tytgat GNJ, Houthoff HJ, Van Den Tweel JG. Barrett's esophagus: development of dysplasia and carcinoma. Gastroenterology 1989;96:1249-56.
11. Hamilton SR, Smith RRL. The relation between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's oesophagus. Am J Clin Pathol 1987;87:301-12.
12. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988;19:942-8.
13. Li H, Walsh TN, O'Dowd G, Gillen P, Byrne PJ, Hennessy TPJ. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus. Surgery 1994;115:176-81.
14. Ortiz A, Martinez de Haro LF, Parrilla P, et al. Conservative treatment versus anti-reflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg 1996;83:274-8.
15. Overholt BF, Panjehpour M. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer. Semin Surg Oncol 1995;11:372-6.
16. Overholt B, Panjehpour M, Tefftellar E, Rose M. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 1993;39:73-6.
17. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
18. Regula J, MacRobert AJ, Gorchein A, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study. Gut 1995;36:67-75.
19. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus and sequelae of therapy. Am J Surg Pathol 1996;20(suppl 1):31-50.
20. Sampliner RE. Effect of up to 3 years of high-dose Lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994;10:1844-8.
21. Sampliner RE, Fass R. Partial regression of Barrett's esophagus - an inadequate endpoint. Am J Gastroenterol 1993;88:2092-4.
22. Sampliner RE, Steinbronn K, Garewal HS, Riddell RH. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery. Am J Gastroenterol 1988;83:510-2.
23. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983;198:554-66.
24. Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989;30:14-8.